Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

NCRI 2012

4 - 7 Nov 2012
ACV - AUSTRIA CENTER VIENNA, Vienna, Austria
Videos
News
Patient led funding for clinical trials
Dr Ian Lewis – Tenovus, Cardiff, UK
Patient led funding for clinical trials ( Dr Ian Lewis – Tenovus, Cardiff, UK )
15 Nov 2012
Perception of inequalities in care and cancer registries
Sir Michael Richards – Department of Health, UK
Perception of inequalities in care and cancer registries ( Sir Michael Richards – Department of Health, UK )
15 Nov 2012
Advances in haemato-oncological treatment options
Prof Kenneth Anderson – Dana Farber Cancer Institute, Boston, UK
Advances in haemato-oncological treatment options ( Prof Kenneth Anderson – Dana Farber Cancer Institute, Boston, UK )
15 Nov 2012
Benefits of partaking in clinical trials
Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS...
Benefits of partaking in clinical trials ( Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National Cancer Peer Review, UK )
15 Nov 2012
Collaborations in clinical trials to bring new drugs to patients earlier
Dr Matt Seymour – National Cancer Research Network
Collaborations in clinical trials to bring new drugs to patients earlier ( Dr Matt Seymour – National Cancer Research Network )
14 Nov 2012
Therapeutic exercise for patients with advanced cancer
Dr Matthew Maddocks – University of Nottingham, UK
Therapeutic exercise for patients with advanced cancer ( Dr Matthew Maddocks – University of Nottingham, UK )
14 Nov 2012
Inequalities in cancer incidence, mortality and survival
Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK
Inequalities in cancer incidence, mortality and survival ( Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK )
14 Nov 2012
Cancer in developing countries
Dr Ian Magrath – International Network for Cancer Research and Treatment...
Cancer in developing countries ( Dr Ian Magrath – International Network for Cancer Research and Treatment, Brussels, Belgium )
14 Nov 2012
Benefit of exercise to cancer survivors
Dr Johannes Brug – VU University Medical Centre, Amsterdam, Netherlands
Benefit of exercise to cancer survivors ( Dr Johannes Brug – VU University Medical Centre, Amsterdam, Netherlands )
14 Nov 2012
Management of hepatocellular carcinoma
Dr Jean-Francois Dufour – University of Bern, Switzerland
Management of hepatocellular carcinoma ( Dr Jean-Francois Dufour – University of Bern, Switzerland )
14 Nov 2012
Development of future cancer treatments
Dr Herbie Newell - Northern Institute for Cancer Research, Newcastle, UK
Development of future cancer treatments ( Dr Herbie Newell - Northern Institute for Cancer Research, Newcastle, UK )
14 Nov 2012
Tissue donation and clinical trials
Adrienne Morgan – VNCRI & NCRN Consumer Liaison Group
Tissue donation and clinical trials ( Adrienne Morgan – VNCRI & NCRN Consumer Liaison Group )
14 Nov 2012
The importance of hereditary genes to cancer susceptibility
Dr Judy Garber – Dana Farber Cancer Institute, Boston, USA
The importance of hereditary genes to cancer susceptibility ( Dr Judy Garber – Dana Farber Cancer Institute, Boston, USA )
14 Nov 2012
Drug susceptibility in cancer cell lines
Dr Lodewyk Wessels – Netherlands Cancer Institute, Amsterdam
Drug susceptibility in cancer cell lines ( Dr Lodewyk Wessels – Netherlands Cancer Institute, Amsterdam )
14 Nov 2012
Depression in cancer patients
Prof Mari Lloyd-Williams – University of Liverpool, UK
Depression in cancer patients ( Prof Mari Lloyd-Williams – University of Liverpool, UK )
14 Nov 2012
Influence of cachexia on chemotherapy toxicity
Dr Michael Sawyer – University of Alberta, Canada
Influence of cachexia on chemotherapy toxicity ( Dr Michael Sawyer – University of Alberta, Canada )
14 Nov 2012
Advances in the treatment of colorectal cancer
Dr Patrick Johnston - Queens University, Belfast, UK
Advances in the treatment of colorectal cancer ( Dr Patrick Johnston - Queens University, Belfast, UK )
14 Nov 2012
New genetic sub-types of breast, ovarian and prostate cancer
Dr Paul Pharoah – University of Cambridge, UK
New genetic sub-types of breast, ovarian and prostate cancer ( Dr Paul Pharoah – University of Cambridge, UK )
14 Nov 2012
A new approach to charity helpline services
Dr Rachel Iredale – Tenovus, Cardiff, UK
A new approach to charity helpline services ( Dr Rachel Iredale – Tenovus, Cardiff, UK )
14 Nov 2012
A national study of cancer patient experiences
Dr Reg Race – Quality Health, Debyshire, UK
A national study of cancer patient experiences ( Dr Reg Race – Quality Health, Debyshire, UK )
14 Nov 2012
Inequalities in cancer treatments
Dr Tony Moran – Christie NHS Foundation, Manchester, UK
Inequalities in cancer treatments ( Dr Tony Moran – Christie NHS Foundation, Manchester, UK )
14 Nov 2012
Advances in the treatment of prostate cancer
Prof Malcolm Mason – Cardiff University, UK
Advances in the treatment of prostate cancer ( Prof Malcolm Mason – Cardiff University, UK )
14 Nov 2012
Diet and exercise interventions for cancer survivors
Prof Wendy Demark-Wahnefried – UAB Comprehensive Cancer Center, Birmingham...
Diet and exercise interventions for cancer survivors ( Prof Wendy Demark-Wahnefried – UAB Comprehensive Cancer Center, Birmingham, Alabama, USA )
14 Nov 2012
Participation in clinical trials
Richard Stephens – VNCRI and NCRN Consumer Liaison Groups
Participation in clinical trials ( Richard Stephens – VNCRI and NCRN Consumer Liaison Groups )
14 Nov 2012
Patient involvement in improvements in standard of care
Tom Haswell - VNCRI and NCRN Consumer Liaison Groups
Patient involvement in improvements in standard of care ( Tom Haswell - VNCRI and NCRN Consumer Liaison Groups )
14 Nov 2012
Benefits of participating in clinical trials and patient liaison groups
Shirley Harrison - VNCRI and NCRN Consumer Liaison Groups
Benefits of participating in clinical trials and patient liaison groups ( Shirley Harrison - VNCRI and NCRN Consumer Liaison Groups )
14 Nov 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation